UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000027107
Receipt number R000030261
Scientific Title Efficacy of subcutaneous continuous glucose monitoring on intraoperative glycemic control
Date of disclosure of the study information 2017/04/24
Last modified on 2019/11/17 14:23:04

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Efficacy of subcutaneous continuous glucose monitoring on intraoperative glycemic control

Acronym

Efficacy of subcutaneous continuous glucose monitoring on intraoperative glycemic control

Scientific Title

Efficacy of subcutaneous continuous glucose monitoring on intraoperative glycemic control

Scientific Title:Acronym

Efficacy of subcutaneous continuous glucose monitoring on intraoperative glycemic control

Region

Japan


Condition

Condition

Patients undergoing cardiovascular surgery using cardiopulmonary bypass

Classification by specialty

Anesthesiology Cardiovascular surgery

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To investigate the efficacy of intraoperative subcutaneous continuous glucose monitoring system in patients undergoing cardiovascular surgery using cardiopulmonary bypass compared with standard care.

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

The primary outcome is the difference in mean blood glucose concentration 120 minutes after detachment of cardiopulmonary bypass

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Open -but assessor(s) are blinded

Control

Active

Stratification

YES

Dynamic allocation

YES

Institution consideration

Institution is not considered as adjustment factor.

Blocking

YES

Concealment

No need to know


Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Device,equipment

Interventions/Control_1

For patients in the subcutaneous continuous glucose monitoring group, an updated glucose value was visible on screen every 5 minutes during surgery and was used to guide treatment.

Interventions/Control_2

For patients in the standard care group, the screen
was turned blank, arterial blood glucose concentration is measured every 60-120 minutes according to standard care.

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Patients undergoing cardiovascular surgery using cardiopulmonary bypass

Key exclusion criteria

Having insulin allergy and a state of blood coagulation disorder

Target sample size

40


Research contact person

Name of lead principal investigator

1st name Ryo
Middle name
Last name Wakabayashi

Organization

Shinshu University School of Medicine

Division name

Department of Anesthesiology and Resuscitology

Zip code

390-8621

Address

3-1-1, Asahi, Matsumoto, Nagano, Japan

TEL

0263-37-2670

Email

waka0924@shinshu-u.ac.jp


Public contact

Name of contact person

1st name Ryo
Middle name
Last name Wakabayashi

Organization

Shinshu University School of Medicine

Division name

Department of Anesthesiology and Resuscitology

Zip code

390-8621

Address

3-1-1, Asahi, Matsumoto, Nagano, Japan

TEL

0263-37-2670

Homepage URL


Email

waka0924@shinshu-u.ac.jp


Sponsor or person

Institute

Shinshu University School of Medicine, Department of Anesthesiology and Resuscitology

Institute

Department

Personal name



Funding Source

Organization

Self funding

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Shinshu University School of Medicine, Institutional Review Board

Address

3-1-1, Asahi, Matsumoto, Nagano, Japan

Tel

0263-37-2572

Email

mdrinri@shinshu-u.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2017 Year 04 Month 24 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Terminated

Date of protocol fixation

2017 Year 02 Month 15 Day

Date of IRB

2017 Year 07 Month 05 Day

Anticipated trial start date

2017 Year 07 Month 06 Day

Last follow-up date

2017 Year 07 Month 06 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2017 Year 04 Month 24 Day

Last modified on

2019 Year 11 Month 17 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000030261


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name